谷歌浏览器插件
订阅小程序
在清言上使用

Comparison of Peripheral Blood Markers in Predicting the Occurrence of Immune-Related Adverse Events in Patients with Metastatic Genitourinary Cancer Treated with Cabozantinib + Nivolumab +/- Ipilimumab.

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览36
关键词
Biomarkers for Immunotherapy,Prognostic Markers,Tumor Microenvironment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要